Effects of highly active antiretroviral therapy on renal function of HIV-infected under-fives in Southern Nigeria
Main Article Content
Abstract
Background: Toxicities from antiretrovirals caused clinically-relevant organ damage.
Objective: Study aimed at monitoring effects of Highly Active Antiretroviral Therapy (HAART) on kidney of HIV-infected under-fives in Southern Nigeria.
Methods: In Southern Nigeria, 238 under-fives were recruited. Institutional approval and written consent were obtained. Group A consisted of 91 HIV-infected children on HAART. Group B1 consisted of 24 HIVexposed infants born to breast feeding HIV-mothers on HAART, who received nevirapine for first 6-week of life. Group B2 (18) and B3 (48) consisted of HIV-exposed children on co-trimoxazole at age 6-month and 18- month respectively. Group C consisted of 11 HIV-infected children on co-trimoxazole. Group D consisted of 46 seronegative children. A 2ml blood was collected from each participant during first phase of the study and ® was analysed for creatinine using Randox kits. Group A returned for second and third phase of the study after 3 and 6 months respectively. Data was analysed by using ANOVA.
Results: Creatinine clearance was highest in group A (102.6±82.9ml/min/1.732m ) suggesting normal renal function. Second phase, creatinine clearance of group A was reduced by 8.7% (p>0.05). Third phase, creatinine clearance was reduced by 25.4% (p<0.05) suggesting reduced renal function.
Conclusion: HAART was significantly associated with reduced renal function among HIV-infected under-fives in Southern Nigeria.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Health Organization (2010). Antiretroviral therapy for HIV infection in infants and children: Towards universal access: Recommendations for public health approach- 2010 Revision. www.who.int. Retrieved on 23 May 2014.
World Health Organization (2006). Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: Towards universal access; recommendation for a public health approach. www.who.int. Retrieved on 23 April 2014.
Deeks SG, Lewin SR and Havlir DV (2013). The end of AIDS: HIV infection as a chronic disease. Lancet 382(9903): 1525–3. doi:10.1016/S0140-
(13)61809-7.
Peter PJ, Moore DM, Mermin J, Brooks JT, Downing R, Were W, Kigozi A, Buchacz K and Weidle PJ (2008). Antiretroviral therapy improves renal function among HIV - i nfected Ugandans . Kidney International 74: 925-9.
Rho M and Perazella MA (2007). Nephrotoxicity associated with antiretroviral in HIV-infected patients. Current Drug Safety 2(2): 147-4. rd
Cochran WG (1977). Sampling techniques. 3 ed. Wiley, United States of America, pp. 1- 8.
Schwartz GJ, Haycock GB, Edelmann CM Jr and Spitzer A (1976). A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259-3.
Bloomfield GS, Hogan JW, Keter A, Sang E, Carter EJ, Velazquez EJ and Kimaiyo S (2011). Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS One 6:e22288. [PubMed: 21779407]. Retrieved 5 August 2013.
Jeffrey KA (2012). Side effects of drugs annual: A worldwide yearly survey of new data in adverse drug reactions . Elsevier 34 : 528 - 9 .
ISBN9780444537416. Retrieved 20 May 2012.
Madeddu G, Quirino T, Carradori S, Ricci E, Grosso C, Penco G, De Socio G, Rossella E, Palvarini L, Marconi P, Melzi S, Mura MS, Bonfanti P and Gruppo CISAI (2006). Renal toxicity of HIV-infected patients receiving HAART including Tenofovir. Infezioni in Medicina 14(3): 125-4.